A Review of Animal and Human Studies for Management of Benign Prostatic Hyperplasia with Natural Products: Perspective of New Pharmacological Agents

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|11|3|207-221

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.11, Iss.3, 2012-06, pp. : 207-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Pharmacological Therapies for the Management of Benign Prostatic Hyperplasia

By Cohen Seth A.   Parsons J. Kellogg  

Drugs & Aging, Vol. 29, Iss. 4, 2012-04 ,pp. : 275-284

Adis International

Access to resources Recommend Favorite

Combination Therapy for the Pharmacological Management of Benign Prostatic Hyperplasia: Rationale and Treatment Options

By Sandhu Jaspreet S.  

Drugs & Aging, Vol. 22, Iss. 11, 2005-01 ,pp. : 901-912

Adis International

Access to resources Recommend Favorite

Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms-action of two new agents

By Kumar Rajeev  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 582-593

Springer Publishing Company

Access to resources Recommend Favorite

Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 14, 2017-08 ,pp. : 1346-1363

Bentham Science Publishers

Access to resources Recommend Favorite

Alfuzosin: A Review of the Therapeutic Use of the Prolonged-Release Formulation Given Once Daily in the Management of Benign Prostatic Hyperplasia

By McKeage K.   Plosker G.L.  

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 633-653

Adis International

Access to resources Recommend Favorite